What is the ticker symbol for Codiak BioSciences?

Codiak BioSciences trades under the ticker CDAK on NASDAQ.

What sector does Codiak BioSciences operate in?

Codiak BioSciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CDAK in a portfolio?

PortView shows CDAK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Codiak BioSciences (CDAK) Stock Analysis

NASDAQHealthcareBiotechnology

$0.06+0.00%

1-year price historyRange $0.01 – $4.14

52-week range$0.06

$0.02$4.25

What Codiak BioSciences does

Codiak BioSciences, Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to pioneering exosome-derived treatments. Its focus spans numerous health challenges, encompassing various cancers (oncology and neuro-oncology), neurological conditions, neuromuscular disorders, and infectious diseases. Leading its pipeline are exoSTING and exoIL-12, both exosome therapeutic candidates engineered to combat a range of solid tumors. Furthermore, the company is progressing exoASO-STAT6, an antisense oligonucleotide specifically targeting the STAT6 transcription factor, as well as exoVACC, a versatile platform for crafting highly precise vaccines. Codiak maintains strategic alliances with several prominent institutions and companies, including Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, the Ragon Institute of MGH, MIT, and Harvard. The enterprise was established in 2015 and is headquartered in Cambridge, Massachusetts.

Key metrics

Market cap

P/E (TTM)

-0.12

EPS (TTM)

$-0.46

Beta

3.93

Dividend yield

0.00%

Revenue / share

$1.05

50-day avg

$0.41

200-day avg

$1.00

52-week high

$4.25

52-week low

$0.02

CEO

Douglas Edward Williams

ETFs linked to CDAK

Broad-market and Healthcare sector ETFs an investor holding Codiak BioSciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CDAK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CDAK in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Codiak BioSciences?: Codiak BioSciences trades under the ticker CDAK on NASDAQ.
Which exchange is CDAK listed on?: CDAK is listed on NASDAQ.
What sector does Codiak BioSciences operate in?: Codiak BioSciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CDAK in a portfolio?: PortView shows CDAK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.